Rxivist logo

HIV-1 Vpr Degrades TET2 to Suppress IRF7 and Interferon Expression in Plasmacytoid Dendritic Cells

By Qi Wang, Li-Chung Tsao, Lei Lv, Yanping Xu, Liang Cheng, Haisheng Yu, Liguo Zhang, Yue Xiong, Lishan Su

Posted 30 Oct 2019
bioRxiv DOI: 10.1101/823328

Plasmacytoid dendritic cells (pDCs) are the major source of type I interferons (IFN-I) in rapid response to viral infections, with constitutive expression of interferon regulatory factor 7 (IRF7). HIV-1 expresses several accessory proteins to counteract specific IFN-induced host restriction factors. As one abundant virion-associated protein, HIV-1 Vpr remains enigmatic in enhancing HIV-1 infection via unclear mechanisms. Here we report that Vpr impaired IFN-I induction in pDCs to enhance HIV-1 replication in CD4+ T cells. Blockade of IFN-I signaling abrogated the effect of Vpr on HIV-1 replication. Virion-associated Vpr suppressed IFN-I induction in pDC by TLR7 agonists. Modulation of IFN-I induction by Vpr was genetically dependent on its activity of TET2 degradation. We further demonstrate that Vpr-mediated TET2 degradation reduced expression of IRF7 in pDCs. Finally, degradation of TET2 in pDCs by Vpr reduced the demethylation level of the IRF7 promoter via CXXC5-dependent recruitment. We conclude that HIV-1 Vpr functions to promote HIV-1 replication by suppressing TET2-dependent IRF7 expression and IFN-I induction in pDCs. The Vpr-TET2-IRF7 axis provides a novel therapeutic target to control HIV-1 infection.

Download data

  • Downloaded 392 times
  • Download rankings, all-time:
    • Site-wide: 112,838
    • In immunology: 3,330
  • Year to date:
    • Site-wide: 119,806
  • Since beginning of last month:
    • Site-wide: 101,382

Altmetric data

Downloads over time

Distribution of downloads per paper, site-wide